Labshake search
Citations for R&D Systems :
1601 - 1650 of 3688 citations for En 1948 4 Marker Pcb Extraction Spike 13C12 99% 100 Ng Ml In Nonane since 2019
Citations are collected from bioRxiv only, the total number of publications could be much larger.
-
bioRxiv - Cancer Biology 2020Quote: ... Invasion was also quantified in response to serum-free DMEM supplemented with 10 ng/mL of recombinant mouse CSF2 (R&D Systems, 415-ML-5), PBS or conditioned media from lung stromal cells from HFD-fed mice treated with 5 μg/mL of either CSF2 neutralizing antibodies (R&D Systems ...
-
bioRxiv - Cell Biology 2023Quote: ... supplemented with 10% FBS and 1% penicillin/streptomycin with macrophage-colony stimulating factor (M-CSF, 30 ng/mL; 416-ML, R&D systems, Minneapolis, MN, USA) for 4 days to obtain BMMs ...
-
bioRxiv - Immunology 2019Quote: ... ILC3 were stimulated with IL-23 (100-300 pg/mL, R&D systems) and/or VIPR2 ligands (BAY-559837 ...
-
bioRxiv - Neuroscience 2023Quote: ... 100 μl of 0.5 mg/ml sheep anti-ITGB5 (R&D Systems, AF3824) was added into 5-10 ml of cell suspension and incubated with the cells for 30-40 min at 37°C ...
-
bioRxiv - Immunology 2021Quote: ... Macrophages and neutrophils were primed where indicated with recombinant murine IFN-g (50 ng/ml, R&D Systems) for 1 hour (for neutrophil cultures ...
-
bioRxiv - Cell Biology 2022Quote: ... media was switched to Basal Neural Maintenance Media with 20 ng/mL FGF (R&D Systems, Minneapolis, MN) and fed daily ...
-
bioRxiv - Neuroscience 2021Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Genomics 2019Quote: ... the medium was changed to STEMdif APEL 2 with 200 ng/mL FGF9 (R&D Systems, Minneapolis, MN) and 1 mg/mL heparin (StemCell Technologies ...
-
bioRxiv - Genomics 2019Quote: ... A control well containing 480 ng/ml of neutratlizing anti-LIF antibody (R&D Systems AB-449-NA) was also plated ...
-
bioRxiv - Bioengineering 2020Quote: ... a mix of recombinant mouse cytokines: 10 ng mL−1 TNF-α (R&D Systems # 410-MT-010), 10 ng mL−1 IL-1α (R&D Systems # 400-ML-005) ...
-
bioRxiv - Biophysics 2020Quote: ... and differentiated into macrophages with 50 ng/mL granulocyte macrophage colony-stimulating factor (GM-CSF, R&D Systems) for 6d prior to infection.
-
bioRxiv - Microbiology 2021Quote: ... the culture medium of BMMs was further supplemented with 1 ng/mL TNF-α (R&D system, USA) and 1 ng/mL IFN-γ (R&D system ...
-
bioRxiv - Developmental Biology 2021Quote: ... in the presence or absence of 50 ng/ml recombinant mouse IGF2 (R&D Systems, 792-MG-050), and collected every 24 hours over a period of four days ...
-
bioRxiv - Molecular Biology 2020Quote: ... A mix of recombinant 10 ng/ml IL6 or IL6/IL6R complexes (R&D Systems, Minneapolis, MN, USA), with or without EVs ...
-
bioRxiv - Developmental Biology 2021Quote: ... animals were incubated in 250 ng/mL recombinant zebrafish BMP4 protein (R&D Systems, cat. 1128-BM-010) in 0.08% bovine serum albumin (BSA ...
-
bioRxiv - Cancer Biology 2022Quote: ... Naïve CD8+ T cells were cultured in R10 media containing 5 ng/mL IL-7 (R&D systems). C57BL/6 CD8+ T cells were purified using the EasySep Mouse CD8 T Cell Isolation Kit (Stemcell technologies ...
-
bioRxiv - Bioengineering 2022Quote: ... Microvessels with and without 24 h treatment with 5 ng mL-1 human recombinant TNFα (R&D Systems), were perfused with THP1s under low shear stress (∼0.2 dyne cm-2 ...
-
bioRxiv - Bioengineering 2022Quote: ... media in the top compartment was replaced with recombinant human TNFα (0.1 ng/mL, R&D Systems, 210TA) and recombinant human IFNγ (2 IU/mL ...
-
bioRxiv - Developmental Biology 2022Quote: ... 1 mM sodium pyruvate and 0.1 mM 2-mercaptoethanol) containing 50 ng/ml of ACTA (R&D Systems), 3 μM CHIR99021 (Tocris Bioscience ...
-
bioRxiv - Biochemistry 2019Quote: ... These wells were suspended above wells containing 5 to 10 ng/mL recombinant human VEGF (R&D Systems) or full serum medium ...
-
bioRxiv - Cell Biology 2019Quote: ... Control medium was then augmented with 10 ng/mL recombinant human TGF-β1 (R&D Systems; chondrogenic media) to induce chondrogenesis ...
-
bioRxiv - Bioengineering 2019Quote: ... Cells were maintained in proliferating state using 10 ng/ml fibroblast growth factor 2 (FGF2; R&D Systems) and passaged twice before usage in the experiments ...
-
bioRxiv - Neuroscience 2020Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Cell Biology 2020Quote: ... to RAW264.7 or 2 ng/mL transforming growth factor β-1(240-B/CF, R&D System, USA) to THP-1 for 24-36 hours ...
-
bioRxiv - Cell Biology 2020Quote: ... the scaffolds were then supplied with ITS basal medium supplemented with 10 ng/mL rhTGFß3 (R&D Systems), 100 nM dexamethasone ...
-
bioRxiv - Cancer Biology 2021Quote: ... This neural medium was supplemented with growth factors EGF (20 ng ml–1, R&D Systems, 236-EG) and FGF2 (20 ng ml–1 ...
-
bioRxiv - Immunology 2020Quote: ... Selected cells were then induced to undergo CSR with TGF-β (1 ng/ml; R&D Systems Europe), IL-4 (5 ng/ml ...
-
bioRxiv - Immunology 2020Quote: ... CD14+ cells were differentiated with 20 ng/mL of macrophage colony-stimulating factor (M-CSF) (R&D systems) for 3 days followed by 3 days of polarization into naïve macrophages (M0 ...
-
bioRxiv - Immunology 2021Quote: ... while Th17 cell cultures were supplemented with IL-6 (20 ng/mL; R&D Systems 206-IL-010), TGF-β (10 ng/mL ...
-
bioRxiv - Immunology 2020Quote: ... and cultured for 6 days with recombinant GM-CSF (R&D Systems cat. 215-GM, 50 ng/ml) and IL-4 (R&D Systems cat ...
-
bioRxiv - Immunology 2022Quote: ... and then treated with 10 ng/mL of recombinant human TGF-b (R&D Systems; 240-B-002) or 10 ng/mL of recombinant human IL-1β (R&D Systems ...
-
bioRxiv - Immunology 2022Quote: ... cells were cultured in the presence of IL-2 (5 ng/ml; R&D Systems, Minneapolis, MN, USA), and in the presence or the absence of CH-223191 or FICZ ...
-
bioRxiv - Biophysics 2023Quote: ... 10 ng/mL recombinant human transforming growth factor beta 1 (TGF-β1 from R&D System, Minnesota, USA). For 3D cultures ...
-
bioRxiv - Cancer Biology 2023Quote: ... The media was replaced after 24h with fresh media containing 2.5 ng/ml TGFβ1 ligand (R&D Systems), with or without 5µM TGFβi (SB-POx ...
-
bioRxiv - Cancer Biology 2023Quote: ... capillaries were filled with 200 ng/mL mouse integrin αvβ3 (7889-AV-050, R&D Systems, Abingdon, UK) and incubated at room temperature for 24 hours ...
-
bioRxiv - Cell Biology 2023Quote: ... 10 ng/mL heregulin-1β (recombinant human NRG-β 1/HRG-β1 EGF domain; R&D Systems, USA), 200 ng/mL recombinant human IGF-1 (LONG R3-IGF-1 ...
-
bioRxiv - Neuroscience 2023Quote: ... and 10 ng/ml of glia cell line-derived neurotrophic factor (GDNF; 212-GD-010, R&D Systems). The cells were placed in an incubator maintained at 37°C and 5% CO2 ...
-
bioRxiv - Microbiology 2023Quote: ... Cells were pretreated with vehicle or 50 ng/mL recombinant human IL-8 (rhIL-8, R&D Systems) 12 h before scratch assay ...
-
bioRxiv - Cell Biology 2023Quote: ... the cells were stimulated with 2 ng/mL recombinant human TGF-β1 (R&D Systems, cat. # 240-B) diluted in starvation medium for varying durations of 30 ...
-
bioRxiv - Genetics 2023Quote: ... medium was changed to anterior primitive streak inducing medium containing 30 ng/ml Activin A (R&D Systems), 4 μM CHIR99021 (Tocris) ...
-
bioRxiv - Neuroscience 2024Quote: ... insulin-like growth factor 1 (10 ng/mL; R&D Systems; Minneapolis, MN; Cat. No. 291-G1-200), brain-derived neurotrophic factor (10 ng/mL ...
-
bioRxiv - Cell Biology 2023Quote: ... after which the cells were exposed for 3 days to 200 ng/ml FGF-9 (R&D systems) and 1μg/mL heparin (Sigma Aldrich ...
-
bioRxiv - Immunology 2021Quote: ... and 1 μg/mL rat anti-mouse IL-4 from R&D Systems (MAB404100) was added ...
-
bioRxiv - Immunology 2020Quote: ... monocytes were cultured with 250 U/ml IL-4 (R&D Systems, Minneapolis, MN) and 800 U/mL GM-CSF (R&D Systems ...
-
bioRxiv - Neuroscience 2022Quote: Pentraxins Binding C1q Purified recombinant neuronal pentraxin proteins (4 µg/mL, R&D Systems) or IgM (2 µg/mL ...
-
bioRxiv - Immunology 2024Quote: ... and 10ng/mL of recombinant human IL-4 (R&D systems, #204-IL/CF). Inhibitors used were the PI3Kdelta inhibitor Idelalisib ...
-
bioRxiv - Cancer Biology 2023Quote: AREG-neutralising experiments were performed by pre-incubating freshly prepared EVs (at 4 x 103 EVs per recipient cell) with either 4 µg/ml of goat anti-AREG (R&D Systems #AF262) or goat anti-IgG (R&D Systems #AB-1080-C ...
-
bioRxiv - Developmental Biology 2022Quote: ... or Noggin (300 ng/μl, R&D Systems, Cat No. 1967-NG) for 48 or 72 hrs ...
-
bioRxiv - Immunology 2023Quote: ... Cells were cultured for 4 days in the presence of 20ng/ml murine recombinant IL-12 (R&D systems; 419-ML). The proportion of IFNγ-secreting CD4+ T-cells (Th1 cells ...
-
bioRxiv - Cell Biology 2022Quote: ... 100 units/mL penicillin and 0.1 mg/mL streptomycin and also with 10μM Y-27632 (ROCK inhibitor; R&D Systems) and 10μM SB 431542 (TGF-βRI inhibitor ...